NEW YORK, Feb. 12 (GenomeWeb News) - LabCorp has become an "early adopter" of Third Wave Technologies' new Invader cytochrome P450 2D6 assay panel, Third Wave said on Tuesday. It is Third Wave's first pharmacogenomics product.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.